Emerging immune checkpoint inhibitors for the treatment of oropharyngeal squamous cell carcinoma

Oropharyngeal Squamous Cell Carcinoma (OPSCC) is a challenging subtype of head and neck cancer that traditionally has been associated with poor prognosis and high morbidity due to the limitations of conventional treatments such as surgery, radiation, and chemotherapy. Immune checkpoint inhibitors ha...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Pandiselvi Ravi, Shyamaladevi Babu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-12-01
Edice:	Oral Oncology Reports
Témata:	Oropharyngeal squamous cell carcinoma Immune checkpoints Inhibitors PD-1/PDL-1 CTLA-4 Pembrolizumab and nivolumab
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2772906024004965
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!